Literature DB >> 18752771

Management of osteoporosis in geriatric populations.

Diane L Schneider1.   

Abstract

The incidence of osteoporotic fractures increases with advancing age and is associated with significant health care expenditures, particularly related to hip fractures and loss of quality of life. Unfortunately, few studies have included subjects 80 years of age and older to help guide management of elderly patients who are living in the community or in long-term care facilities. Treating this age group encompasses the same general measures and pharmacologic therapies as in younger adults. Focusing on fall prevention and adequate vitamin D is essential. All prevention strategies in the elderly for fracture risk reduction should include simple vitamin D and calcium supplementation. However, for those at high risk of fracture, adding pharmacologic therapy should be considered. This article reviews recent research findings of general measures and pharmacologic therapy that are applicable to managing osteoporosis in the elderly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18752771     DOI: 10.1007/s11914-008-0018-4

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  37 in total

Review 1.  Prevention of falls and consequent injuries in elderly people.

Authors:  Pekka Kannus; Harri Sievänen; Mika Palvanen; Teppo Järvinen; Jari Parkkari
Journal:  Lancet       Date:  2005-11-26       Impact factor: 79.321

2.  Preventing falls in elderly people living in hospitals and care homes.

Authors:  Ian D Cameron; Susan Kurrle
Journal:  BMJ       Date:  2007-01-13

3.  Risk factors for falls among elderly persons living in the community.

Authors:  M E Tinetti; M Speechley; S F Ginter
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

4.  Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

Authors:  Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson
Journal:  J Bone Miner Res       Date:  2007-03       Impact factor: 6.741

5.  Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial.

Authors:  A M Grant; A Avenell; M K Campbell; A M McDonald; G S MacLennan; G C McPherson; F H Anderson; C Cooper; R M Francis; C Donaldson; W J Gillespie; C M Robinson; D J Torgerson; W A Wallace
Journal:  Lancet       Date:  2005 May 7-13       Impact factor: 79.321

6.  Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial.

Authors:  Susan L Greenspan; Diane L Schneider; Michael R McClung; Paul D Miller; Thomas J Schnitzer; Randi Bonin; Mary Elizabeth Smith; Paul DeLucca; Glenn J Gormley; Mary E Melton
Journal:  Ann Intern Med       Date:  2002-05-21       Impact factor: 25.391

7.  Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

Authors:  Charles H Chesnut; Arne Skag; Claus Christiansen; Robert Recker; Jacob A Stakkestad; Arne Hoiseth; Dieter Felsenberg; Hermann Huss; Jennifer Gilbride; Ralph C Schimmer; Pierre D Delmas
Journal:  J Bone Miner Res       Date:  2004-03-29       Impact factor: 6.741

8.  Efficacy of a hip protector to prevent hip fracture in nursing home residents: the HIP PRO randomized controlled trial.

Authors:  Douglas P Kiel; Jay Magaziner; Sheryl Zimmerman; Linda Ball; Bruce A Barton; Kathleen M Brown; Judith P Stone; Dawn Dewkett; Stanley J Birge
Journal:  JAMA       Date:  2007-07-25       Impact factor: 56.272

9.  Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.

Authors:  Bruce Ettinger; Javier San Martin; Gerald Crans; Imre Pavo
Journal:  J Bone Miner Res       Date:  2004-01-19       Impact factor: 6.741

10.  Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle.

Authors:  R U Simpson; G A Thomas; A J Arnold
Journal:  J Biol Chem       Date:  1985-07-25       Impact factor: 5.157

View more
  4 in total

1.  Microstructure and nanomechanical properties in osteons relate to tissue and animal age.

Authors:  Jayme Burket; Samuel Gourion-Arsiquaud; Lorena M Havill; Shefford P Baker; Adele L Boskey; Marjolein C H van der Meulen
Journal:  J Biomech       Date:  2010-11-12       Impact factor: 2.712

2.  Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women.

Authors:  Susan L Greenspan; Allison Wyman; Frederick H Hooven; Silvano Adami; Stephen Gehlbach; Frederick A Anderson; Steven Boone; Andrea Z Lacroix; Robert Lindsay; J Coen Netelenbos; Johannes Pfeilschifter; Stuart Silverman; Ethel S Siris; Nelson B Watts
Journal:  J Am Geriatr Soc       Date:  2012-02-08       Impact factor: 5.562

3.  FRAX or fiction: determining optimal screening strategies for treatment of osteoporosis in residents in long-term care facilities.

Authors:  Susan L Greenspan; Subashan Perera; David Nace; Kimberly S Zukowski; Mary A Ferchak; Carroll J Lee; Smita Nayak; Neil M Resnick
Journal:  J Am Geriatr Soc       Date:  2012-02-08       Impact factor: 5.562

4.  Spatial variation in osteonal bone properties relative to tissue and animal age.

Authors:  Samuel Gourion-Arsiquaud; Jayme C Burket; Lorena M Havill; Edward DiCarlo; Stephen B Doty; Richard Mendelsohn; Marjolein C H van der Meulen; Adele L Boskey
Journal:  J Bone Miner Res       Date:  2009-07       Impact factor: 6.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.